Abnormal uterine bleeding
review
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
This paper discusses the complex causes and management strategies for abnormal uterine bleeding, a common gynecological issue.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Concerns about abnormal menstrual bleeding are a common reason for women to consult a primary care physician. The first step in the evaluation is to determine the patient's ovulatory status. Women with heavy bleeding but normal ovulatory cycles should be evaluated for coagulopathies, structural lesions, and hypothyroidism. In the absence of a systemic or structural cause, menorrhagia can be treated with OCPs or NSAIDs. Intermenstrual bleeding in OCP users may be due to noncompliance or the use of low-dose pills. Encouraging patient compliance and adjustment of the estrogen dose can often solve the problem. If the patient is not on OCPs, intermenstrual bleeding is usually due to a structural or inflammatory lesion. The differential diagnosis for anovulatory bleeding is extensive. Pregnancy, systemic illnesses, and structural lesions should be ruled out by history, physical examination, and laboratory evaluation. Endometrial biopsy is indicated in patients over age 35 and younger patients with risk factors for endometrial cancer, such as chronic anovulation and obesity. Dysfunctional uterine bleeding is a nonspecific term for abnormal uterine bleeding in the absence of systemic or structural disease. It is usually associated with anovulation. Adolescents frequently have dysfunctional uterine bleeding owing to immaturity of the hypothalamic-pituitary-ovarian axis. Perimenopausal women have an increased incidence of irregular bleeding secondary to decreased estrogen production by the ovary. Obesity, polycystic ovary syndrome, stress, crash diets, and vigorous exercise can all disrupt normal ovulatory function. Treatment options for dysfunctional uterine bleeding include oral contraceptives, cyclic progesterone, or hormone replacement with estrogen and progesterone. Patients with structural lesions or those who do not resume normal withdrawal bleeding patterns on hormone therapy should be referred to a gynecologist for further evaluation and treatment.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- The prognosis for adolescents with menstrual abnormalities 1966
- Menorrhagia 1990
- Menstrual Problems in Adolescents 1990
Cited by (3)
References (30)
- Menorrhagia via openalex
- Menstrual Problems in Adolescents via openalex
- The prognosis for adolescents with menstrual abnormalities via openalex
- W1848389997 via openalex
- W1892016034 via openalex
- W1990203438 via openalex
- W2011240193 via openalex
- W2012165536 via openalex
- W2025585229 via openalex
- W2042374015 via openalex
- W2043194220 via openalex
- W2050573915 via openalex
- W2056895439 via openalex
- W2087036243 via openalex
- W2092214166 via openalex
- W2097047879 via openalex
- W2121373740 via openalex
- W2275449391 via openalex
- W2404398254 via openalex
- W2434492924 via openalex
- W2468981690 via openalex
- W4299952610 via openalex
- W6602010017 via openalex
- W6602328082 via openalex
- W6639266374 via openalex
- W6673931416 via openalex
- W51706072 via openalex
- W6767279725 via openalex
- W1678246774 via openalex
- W1783602832 via openalex
Cited by (3)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK